CN Patent

CN120225524A — 嘧啶sGC刺激剂

Assigned to Di Shan Duo Pharmaceutical Co · Expires 2025-06-27 · 1y expired

What this patent protects

本公开涉及可溶性鸟苷酸环化酶(sGC)的刺激剂、其药学上可接受的盐和包含它们的药物制剂及它们单独或与一种或多种另外的药剂组合用于治疗各种疾病的用途，其中增加一氧化氮(NO)的浓度和/或增加环磷酸鸟苷(cGMP)的浓度，或两者兼有，或调节NO通路是期望的。在一些实施方案中，化合物是式I的化合物或其药学上可接受的盐。

USPTO Abstract

本公开涉及可溶性鸟苷酸环化酶(sGC)的刺激剂、其药学上可接受的盐和包含它们的药物制剂及它们单独或与一种或多种另外的药剂组合用于治疗各种疾病的用途，其中增加一氧化氮(NO)的浓度和/或增加环磷酸鸟苷(cGMP)的浓度，或两者兼有，或调节NO通路是期望的。在一些实施方案中，化合物是式I的化合物或其药学上可接受的盐。

Drugs covered by this patent

Patent Metadata

Patent number
CN120225524A
Jurisdiction
CN
Classification
—
Expires
2025-06-27
Drug substance claim
No
Drug product claim
No
Assignee
Di Shan Duo Pharmaceutical Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.